Physician profile
Brent Edwards
NPI 1346225489
$782.12
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $629 · 2020: $120 · 2022: $33.11.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $208.00 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $151.30 | 2019-2020 | |
| Amgen INC. | $69.44 | 2019-2020 | |
| Boston Scientific Corporation | $59.52 | 2019-2022 | |
| Astellas Pharma US INC | $54.80 | 2019-2020 | |
| Pfizer INC. | $54.00 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $49.86 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.76 | 2019-2020 | |
| Medtronic Vascular, INC. | $34.42 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $28.75 | 2019 | |
| Sanofi-Aventis U.S. LLC | $19.43 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $10.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brent Edwards listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.